Printer Friendly

Articles from Worldwide Biotech (September 1, 2005)

1-4 out of 4 article(s)
Title Author Type Words
ONCOGENEX BEGINS FIRST OF 4 PHASE 2 CLINICAL 0GX-011 TRIALS. 956
OSI INITIATES PHASE I CLINICAL TRIAL OF PSN357. 670
PHASE IIB STUDY SHOWS REVERSET ACHIEVES ANTIVIRIRAL BENEFIT. 1625
VALEANT BEGINS CLINICAL DEVELOPMENT OF VIRAMIDINE IN JAPAN. 506

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters